1. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials guidance for industry
2. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials;Sateren WB,2002
3. Representation of minorities and women in oncology clinical trials: review of the past 14 years;Duma N,2018
4. FDA analysis of racial demographics in multiple myeloma trials;Bhatnagar V,2017
5. Conducting accessible research: including people with disabilities in public health, epidemiological, and outcomes studies;Rios D,2016